| Inclusion / Exclusion | Inclusion criteria:
For the patients who have participated in and completed a previous
LY2216684 study ("rollover patients"), the first 3 inclusion
criteria must be met at the time of entry into their first LY2216684 study.
For the patients who have never par...Inclusion criteria:
For the patients who have participated in and completed a previous
LY2216684 study ("rollover patients"), the first 3 inclusion
criteria must be met at the time of entry into their first LY2216684 study.
For the patients who have never participated in a previous LY2216684 study
("new patients"), the first 3 Inclusion criteria must be met at
Visit 1 and/or Visit 2 of this study.
1. Patients must be at least 6 years and less than 18 years of age at the
time the informed consent is signed for this trial for new patients. Patients
who rollover from the previous pediatric LY2216684 studies must have met the
age requirement of the parent trials at that enrollment.
2. Patients must meet DSM-IV diagnostic criteria for ADHD (inattentive,
hyperactive/impulsive, or combined subtypes) based on an interview by an
experienced clinician and confirmed using the K-SADS-PL at Visit 1 for new
patients and in the parent trial for rollover patients.
3. Patients must have an ADHDRS-IV-Parent: Inv total score of at least 1.5
standard deviations above the age and gender norm at both Visit 1 and Visit 2
for new patients and the required scores in the parent trial for rollover
patients. In addition, new patients must have a CGI-ADHD-S score ≥ 4 at
both Visit 1 and Visit 2.
More |
